Table 4.
Treatment toxicity for the two group (NBT+EBRT and EBRT).
| Characteristics | NBT+EBRT, N (%) | EBRT N (%) | p value |
|---|---|---|---|
| Acute toxicity | |||
| Esophagitis (RTOG) | 0.427 | ||
| Grade 0–1 | 8(26) | 14(45) | |
| Grade 2–3 | 23 (74) | 17 (55) | |
| Grade 4 | 0 | 0 | |
| Pulmonary complications(RTOG) | 0.341 | ||
| Grade 0–1 | 29(93.6) | 27(87.1) | |
| Grade 2–3 | 2 (6.4) | 4 (12.9) | |
| Grade 4 | 0 | 0 | |
| Hematologic toxicities(WHO) | 0.649 | ||
| Grade 0–1 | 17(55) | 18(58) | |
| Grade 2–3 | 14 (45) | 13 (42) | |
| Grade 4 | 0 | 0 | |
| Late toxicity | 0.537 | ||
| Esophageal fistulas | 2 (6.45) | 2 (6.45) | |
| Massive bleeding | 3 (3.2) | 2(6.45) |
EBRT external beam radiotherapy, NBT neutron intraluminal brachytherapy.